429 related articles for article (PubMed ID: 17879947)
21. The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability.
Stöppler H; Stöppler MC; Adduci A; Koval D; Schlegel R
Virology; 1996 Mar; 217(2):542-53. PubMed ID: 8610446
[TBL] [Abstract][Full Text] [Related]
22. Pro- and anti-apoptotic effects of an inhibitor of chymotrypsin-like serine proteases.
King MA; Halicka HD; Darzynkiewicz Z
Cell Cycle; 2004 Dec; 3(12):1566-71. PubMed ID: 15539954
[TBL] [Abstract][Full Text] [Related]
23. DNA degradation and proteolysis in thymocyte apoptosis.
Fearnhead HO; MacFarlane M; Dinsdale D; Cohen GM
Toxicol Lett; 1995 Dec; 82-83():135-41. PubMed ID: 8597041
[TBL] [Abstract][Full Text] [Related]
24. The characterization of cell death induced by 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd) in FM3A cells.
Takatori S; Tsutsumi S; Hidaka M; Kanda H; Matsuda A; Fukushima M; Wataya Y
Nucleosides Nucleotides; 1998 Aug; 17(8):1309-17. PubMed ID: 9672699
[TBL] [Abstract][Full Text] [Related]
25. Can application of serine protease inhibitors TPCK and TLCK provide evidence for possible involvement of serine protease Omi/HtrA2 in imatinib mesylate-induced cell death of BCR-ABL-positive human leukemia cells?
Mlejnek P
Leukemia; 2005 Jun; 19(6):1085-7. PubMed ID: 15800674
[No Abstract] [Full Text] [Related]
26. Serine protease inhibitors interact with IFN-γ through up-regulation of FasR; a novel therapeutic strategy against cancer.
Shadrin N; Shapira MG; Khalfin B; Uppalapati L; Parola AH; Nathan I
Exp Cell Res; 2015 Jan; 330(2):233-239. PubMed ID: 25449698
[TBL] [Abstract][Full Text] [Related]
27. Two types of death of poliovirus-infected cells: caspase involvement in the apoptosis but not cytopathic effect.
Agol VI; Belov GA; Bienz K; Egger D; Kolesnikova MS; Raikhlin NT; Romanova LI; Smirnova EA; Tolskaya EA
Virology; 1998 Dec; 252(2):343-53. PubMed ID: 9878613
[TBL] [Abstract][Full Text] [Related]
28. Effect of the serine protease inhibitor N-tosyl-l-phenylalanine-chloromethyl ketone (TPCK) on MCF-7 mammary tumour cells growth and differentiation.
Horman S; Del Bino G; Fokan D; Mosselmans R; Galand P
Cell Biol Int; 2000; 24(3):153-61. PubMed ID: 10772776
[TBL] [Abstract][Full Text] [Related]
29. A pre-existing protease is a common effector of thymocyte apoptosis mediated by diverse stimuli.
Fearnhead HO; Rivett AJ; Dinsdale D; Cohen GM
FEBS Lett; 1995 Jan; 357(3):242-6. PubMed ID: 7835420
[TBL] [Abstract][Full Text] [Related]
30. Role of serine and ICE-like proteases in induction of apoptosis by etoposide in human leukemia HL-60 cells.
Yoshida A; Takauji R; Inuzuka M; Ueda T; Nakamura T
Leukemia; 1996 May; 10(5):821-4. PubMed ID: 8656677
[TBL] [Abstract][Full Text] [Related]
31. Calpain inhibitors and serine protease inhibitors can produce apoptosis in HL-60 cells.
Lu Q; Mellgren RL
Arch Biochem Biophys; 1996 Oct; 334(1):175-81. PubMed ID: 8837753
[TBL] [Abstract][Full Text] [Related]
32. Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus.
Scheller C; Knöferle J; Ullrich A; Prottengeier J; Racek T; Sopper S; Jassoy C; Rethwilm A; Koutsilieri E
J Cell Biochem; 2006 Apr; 97(6):1350-61. PubMed ID: 16365881
[TBL] [Abstract][Full Text] [Related]
33. A serine protease inhibitor, N-alpha-tosyl-l-lysine chloromethyl ketone, prolongs rat hepatic allograft survival.
Zhang JL; Yamaguchi Y; Mori K; Okabe K; Hidaka H; Ohshiro H; Uchino S; Ishihara K; Furuhashi T; Yamada S; Ogawa M
J Surg Res; 2001 Apr; 96(2):296-303. PubMed ID: 11266287
[TBL] [Abstract][Full Text] [Related]
34. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents.
Lotem J; Sachs L
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12507-12. PubMed ID: 8901612
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a serine protease-mediated cell death program activated in human leukemia cells.
O'Connell AR; Holohan C; Torriglia A; Lee BW; Stenson-Cox C
Exp Cell Res; 2006 Jan; 312(1):27-39. PubMed ID: 16288739
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis in human monocytic THP.1 cells involves several distinct targets of N-tosyl-L-phenylalanyl chloromethyl ketone (TPCK).
Zhu H; Dinsdale D; Alnemri ES; Cohen GM
Cell Death Differ; 1997 Oct; 4(7):590-9. PubMed ID: 14555972
[TBL] [Abstract][Full Text] [Related]
37. Treatment of cells with n-alpha-tosyl-L-phenylalanine-chloromethyl ketone induces the proteolytic loss of STAT6 transcription factor.
Perez-G M; Cortes JR; Rivas MD; Masa F; Zamorano J
Mol Immunol; 2008 Sep; 45(15):3896-901. PubMed ID: 18676023
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of trypsin-like serine proteases prevent DNA damage-induced neuronal death by acting upstream of the mitochondrial checkpoint and of p53 induction.
Rideout HJ; Zang E; Yeasmin M; Gordon R; Jabado O; Park DS; Stefanis L
Neuroscience; 2001; 107(2):339-52. PubMed ID: 11731108
[TBL] [Abstract][Full Text] [Related]
39. The serine protease inhibitors, tosylphenylalanine chloromethyl ketone and tosyllysine chloromethyl ketone, potently inhibit pp70s6k activation.
Grammer TC; Blenis J
J Biol Chem; 1996 Sep; 271(39):23650-2. PubMed ID: 8798584
[TBL] [Abstract][Full Text] [Related]
40. The effect of serine and thiol protease inhibitors on the chemiluminescence of human neutrophils in investigations in vitro.
Kantorski J; Tchórzewski H
J Biolumin Chemilumin; 1992 Jan; 7(1):37-45. PubMed ID: 1642140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
